br Boutros PC Fraser M Harding NJ de Borja R
 Boutros PC, Fraser M, Harding NJ, de Borja R, Trudel D, Lalonde E, Meng A, Hennings-Yeomans PH, McPherson A, and Sabelnykova VY, et al (2015). Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat Genet 47, 736–745.
 Boyd LK, Mao X, Xue L, Lin D, Chaplin T, Kudahetti SC, Stankiewicz E, Yu Y, Beltran L, and Shaw G, et al (2012). High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer. Genes Chromosomes Cancer 51, 579–589.
 Yoshimoto M, Ludkovski O, DeGrace D, Williams JL, Evans A, Sircar K, Bismar TA, Nuin P, and Squire JA (2012). PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications. Genes Chromosomes Cancer 51, 149–160.
 Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, and Bova GS (1998). Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58, 204–209.
 Man YG, Stojadinovic A, Mason J, Avital I, Bilchik A, Bruecher B, Protic M, Nissan A, Izadjoo M, and Zhang X, et al (2013). Tumor-infiltrating immune JSH 23 promoting tumor invasion and metastasis: existing theories. J Cancer 4, 84–95.
 Jimenez-Sanchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, Gill MB, Park KJ, Zivanovic O, and Konner J, et al (2017). Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient. Cell 170, 927–938 [e920].
 Leonard MK, McCorkle JR, Snyder DE, Novak M, Zhang Q, Shetty AC, Mahurkar AA, and Kaetzel DM (2018). Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma. Lab Invest 98, 327–338.
 Calicchio ML, Collins T, and Kozakewich HP (2009). Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling. Am J Pathol 174, 1638–1649.
 Wong M, Funasaka K, Obayashi T, Miyahara R, Hirooka Y, Hamaguchi M, Goto H, and Senga T (2017). AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors. Oncol Lett 13, 1281–1287.
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/biomaterials
Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment
Chui-Wei Wonga, Hao-Wei Hana, Yu-Wen Tienb,∗∗, Shan-hui Hsua,c,d,∗ a Institute of Polymer Science and Engineering, National Taiwan University, Taipei, Taiwan
b Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
c Research and Development Center for Medical Devices, National Taiwan University, Taipei, Taiwan
d Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan
Human pancreatic ductal adenocarcinoma (PDAC)
Pancreatic stellate cells (PSC)
Pancreatic stromal cells especially pancreatic stellate cells (PSCs) play a critical role in the progression of human pancreatic ductal adenocarcinoma (PDAC). However, the exact interaction between cancer cells and PSCs re-mains to be elucidated in order to develop more eﬀective therapeutic approaches to treat PDAC. The micro-environment of PDAC shows higher hyaluronan (HA) levels, which is associated with poor prognosis of PDAC patients. In the current study, an eﬃcient three-dimensional tumor spheroid model for PDAC was established. The pancreatic cancer cells and PSCs were co-cultured on hyaluronan grafted chitosan (CS-HA) coated plates to generate 3D tumor-like co-spheroids. The pancreatic cancer cells and PSCs (1:9 ratio) co-cultured on CS-HA coated plates were assembled into tumor-like co-spheroids with 3D core-shell structure in 48 h. These spheroids displayed potent in vitro tumorigenicity such as up-regulated expression of stemness and migration markers. The migration rate of cancer cells in spheroids (from 1:9 cell ratio) was much faster (3.2-fold) than that of cancer cells alone. Meanwhile, this unique co-spheroidal cancer cell structure with the outer wrap of PSCs contributed to the chemo-resistance of pancreatic cancer cells to gemcitabine as well as sensitivity to the combined gem-citabine and Abraxane treatment in vitro. The metastatic nature of the spheroids was confirmed by the zebrafish xenograft model in vivo. The compact and dynamic pancreatic cancer-PSC co-spheroids generated by the unique 3D co-culture platform on CS-HA biomaterials can mimic the PSC-constituting microenvironment of PDAC and demonstrate the chemo-resistant, invasive, and metastatic phenotypes. They have potential applications in personalized and high-throughput drug screening.